within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01B_PosteriorPituitaryLobeHormones.H01BA04_Terlipressin;

model Terlipressin
  extends Pharmacolibrary.Drugs.ATC.H.H01BA04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H01BA04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Terlipressin is a synthetic analog of vasopressin used primarily in the management of bleeding esophageal varices and hepatorenal syndrome in patients with liver cirrhosis. It is a prodrug, slowly metabolized to lysine vasopressin (the active form) and is administered intravenously. Terlipressin is approved and in use in several countries for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients with bleeding esophageal varices, both male and female, with impaired liver function. Intravenous administration.</p><h4>References</h4><ol><li><p>Nilsson, G, et al., &amp; Vernersson, E (1990). Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. <i>Drugs under experimental and clinical research</i> 16(6) 307–314. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2086166/&quot;>https://pubmed.ncbi.nlm.nih.gov/2086166</a></p></li><li><p>Pesaturo, AB, et al., &amp; Voils, SA (2006). Terlipressin: vasopressin analog and novel drug for septic shock. <i>The Annals of pharmacotherapy</i> 40(12) 2170–2177. DOI:<a href=&quot;https://doi.org/10.1345/aph.1H373&quot;>10.1345/aph.1H373</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17148649/&quot;>https://pubmed.ncbi.nlm.nih.gov/17148649</a></p></li><li><p>Bateman, RM, et al., &amp; Prandi, E (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. <i>Critical care (London, England)</i> 20(Suppl 2) 94–None. DOI:<a href=&quot;https://doi.org/10.1186/s13054-016-1208-6&quot;>10.1186/s13054-016-1208-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27885969/&quot;>https://pubmed.ncbi.nlm.nih.gov/27885969</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Terlipressin;
